World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
90
Citations
35816
World Ranking
675
National Ranking
19

Medicine

D-Index
94
Citations
40268
World Ranking
10332
National Ranking
287

Yoshiyuki Suzuki publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Yoshiyuki Suzuki sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 726 publications — 99th percentile

99% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Yoshiyuki Suzuki D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Yoshiyuki Suzuki sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 90 D-Index — 88th percentile

88% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Yoshiyuki Suzuki is affiliated with Fukushima Medical University in Japan, conducting research primarily in the field of medicine. Their work spans multiple subfields including epidemiology, hepatology, oncology, surgery, and pulmonary and respiratory medicine.

The main topics covered in Suzuki's research include liver disease diagnosis and treatment, hepatocellular carcinoma treatment and prognosis, hepatitis B virus studies, hepatitis C virus research, liver disease and transplantation, MRI in cancer diagnosis, and pancreatic and hepatic oncology research.

Recent notable publications by Suzuki and collaborators include:

  • Prognostic Impact of Surgical Intervention After Lenvatinib Treatment for Advanced Hepatocellular Carcinoma, 2021, Annals of Surgical Oncology
  • Lenvatinib-Transarterial Chemoembolization Sequential Therapy as an Effective Treatment at Progression during Lenvatinib Therapy for Advanced Hepatocellular Carcinoma, 2020, Liver Cancer
  • Efficacy and Safety of the siRNA JNJ-73763989 and the Capsid Assembly Modulator JNJ-56136379 (Bersacapavir) with Nucleos(t)ide Analogues for the Treatment of Chronic Hepatitis B Virus Infection (REEF-1): A Multicentre, Double-Blind, Active-Controlled, Randomised, Phase 2b Trial, 2023, The Lancet. Gastroenterology & Hepatology
  • Phase IIa, Randomised, Double-Blind Study of GSK3389404 in Patients with Chronic Hepatitis B on Stable Nucleos(t)ide Therapy, 2022, Journal of Hepatology
  • SGLT2 Inhibitor Treatment Outcome in Nonalcoholic Fatty Liver Disease Complicated with Diabetes Mellitus: The Long-term Effects on Clinical Features and Liver Histopathology, 2020, Internal Medicine

Frequent coauthors in their research include:

  • Yusuke Kawamura
  • Norio Akuta
  • Fumitaka Suzuki
  • Hiromitsu Kumada
  • Tetsuya Hosaka

Publication venues where Suzuki has a significant presence are:

  • Hepatology Research
  • Oncology
  • Internal Medicine
  • Clinical Journal of Gastroenterology
  • BMC Gastroenterology

Best Publications

  • Genetic Analysis of Human Norovirus Strains in Japan in 2016-2017.

    Koo Nagasawa;Yuki Matsushima;Takumi Motoya;Fuminori Mizukoshi

  • Long‐term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection

    Tetsuya Hosaka;Fumitaka Suzuki;Masahiro Kobayashi;Yuya Seko

  • Mapping human genetic diversity in Asia

    Mahmood Ameen Abdulla;Ikhlak Ahmed;Anunchai Assawamakin;Anunchai Assawamakin;Jong Bhak

  • DNA double-strand break repair pathway regulates PD-L1 expression in cancer cells

    Hiro Sato;Atsuko Niimi;Takaaki Yasuhara;Tiara Bunga Mayang Permata

  • Effect of interferon therapy on hepatocellular carcinogenesis in patients with chronic hepatitis type C: A long-term observation study of 1,643 patients using statistical bias correction with proportional hazard analysis.

    Kenji Ikeda;Satoshi Saitoh;Yasuji Arase;Kazuaki Chayama

  • Daclatasvir plus asunaprevir for chronic HCV genotype 1b infection.

    Hiromitsu Kumada;Yoshiyuki Suzuki;Kenji Ikeda;Joji Toyota

  • Endogenous non-retroviral RNA virus elements in mammalian genomes

    Masayuki Horie;Tomoyuki Honda;Tomoyuki Honda;Yoshiyuki Suzuki;Yuki Kobayashi

  • Disease progression and hepatocellular carcinogenesis in patients with chronic viral hepatitis: a prospective observation of 2215 patients

    Kenji Ikeda;Satoshi Saitoh;Yoshiyuki Suzuki;Masahiro Kobayashi

  • Emergence and takeover of YMDD motif mutant hepatitis B virus during long-term lamivudine therapy and re-takeover by wild type after cessation of therapy

    Kazuaki Chayama;Yoshiyuki Suzuki;Masahiro Kobayashi;Mizuho Kobayashi

  • Interferon beta prevents recurrence of hepatocellular carcinoma after complete resection or ablation of the primary tumor—A prospective randomized study of hepatitis C virus–related liver cancer

    Kenji Ikeda;Yasuji Arase;Satoshi Saitoh;Masahiro Kobayashi

  • The Prognostic Significance of Phosphatidylinositol 3-Kinase Pathway Activation in Human Gliomas

    Arnab Chakravarti;Gary Zhai;Yoshiyuki Suzuki;Sormeh Sarkesh

  • Integrative Annotation of 21,037 Human Genes Validated by Full-Length cDNA Clones

    Tadashi Imanishi;Takeshi Itoh;Yutaka Suzuki;Claire O'Donovan

  • The long term efficacy of glycyrrhizin in chronic hepatitis C patients

    Unknown

  • Phylogenetic analysis of the complete genome of 18 Norwalk-like viruses.

    Kazuhiko Katayama;Haruko Shirato-Horikoshi;Shigeyuki Kojima;Tsutomu Kageyama

  • Predictive factors of early and sustained responses to peginterferon plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus genotype 1b: Amino acid substitutions in the core region and low-density lipoprotein cholesterol levels

    Norio Akuta;Fumitaka Suzuki;Yusuke Kawamura;Hiromi Yatsuji

  • Association of Amino Acid Substitution Pattern in Core Protein of Hepatitis C Virus Genotype 1b High Viral Load and Non-Virological Response to Interferon-Ribavirin Combination Therapy

    Norio Akuta;Fumitaka Suzuki;Hitomi Sezaki;Yoshiyuki Suzuki

  • Chemical chaperone therapy for brain pathology in GM1-gangliosidosis

    Junichiro Matsuda;Osamu Suzuki;Akihiro Oshima;Yoshie Yamamoto

  • Amino acid substitution in hepatitis C virus core region and genetic variation near the interleukin 28B gene predict viral response to telaprevir with peginterferon and ribavirin

    Norio Akuta;Fumitaka Suzuki;Miharu Hirakawa;Yusuke Kawamura

  • Sustained virological response reduces incidence of onset of type 2 diabetes in chronic hepatitis C

    Yasuji Arase;Fumitaka Suzuki;Yoshiyuki Suzuki;Norio Akuta

  • Large-scale long-term follow-up study of Japanese patients with non-alcoholic Fatty liver disease for the onset of hepatocellular carcinoma.

    Yusuke Kawamura;Yasuji Arase;Kenji Ikeda;Yuya Seko

  • RAPID COMMUNICATION Daclatasvir Plus Asunaprevir for Chronic HCV Genotype 1b Infection

    Hiromitsu Kumada;Yoshiyuki Suzuki;Kenji Ikeda;Joji Toyota

Frequent Co-Authors

Hiromitsu Kumada
Hiromitsu Kumada Fukuoka University
Masahiro Kobayashi
Masahiro Kobayashi Toranomon Hospital
Yasuji Arase
Yasuji Arase University of Yamanashi
Kenji Ikeda
Kenji Ikeda University of California, San Francisco
Fumitaka Suzuki
Fumitaka Suzuki Toranomon Hospital
Satoshi Saitoh
Satoshi Saitoh Toranomon Hospital
Tetsuya Hosaka
Tetsuya Hosaka Toranomon Hospital
Hitomi Sezaki
Hitomi Sezaki Toranomon Hospital
Mariko Kobayashi
Mariko Kobayashi Kaohsiung Medical University
Kazuaki Chayama
Kazuaki Chayama Hiroshima University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA can open diverse career paths, many of which are accessible through online degrees. For individuals with unique challenges, exploring degrees felons can get highlights options that allow for educational advancement despite prior records. This inclusivity supports broader access to scientific and healthcare fields.

Many Microbiology graduates pursue specialized healthcare roles. For instance, becoming a functional medicine nurse practitioner is a promising option that merges microbiology knowledge with patient-centered care. This career path requires advanced education but offers rewarding opportunities in integrative health.

Alternatively, those interested in administrative and technical aspects of healthcare might consider certification in areas like medical coding. Understanding the certified professional coder salary and career paths can guide Microbiology graduates toward stable jobs in healthcare documentation and billing.

Similarly, careers in health information management offer potential for combining scientific and data management skills. Exploring health information management jobs salary and pathways provides insight into roles that support healthcare systems through data oversight and compliance.

Overall, online degrees paired with the right certifications can expand career options for Microbiology students, shaping versatile and sustainable professional futures.

Best Scientists Citing Yoshiyuki Suzuki

Trending Scientists

Recently Published Articles